Canaccord lowered the firm’s price target on Waldencast (WALD) to $4 from $5 and keeps a Buy rating on the shares. The firm noted they announced their previously delayed 2Q results and also provided 3Q sales performance. Sales in both quarters came in below our and management’s initial expectations, primarily due to weakness from the Milk Makeup brand. Looking ahead, management now expects sales for FY25 to be broadly in-line with FY24’s sales.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Waldencast downgraded to Market Perform from Outperform at Telsey Advisory
- Waldencast Reports Mixed Q2 and Q3 2025 Results
- Midday Fly By: Novo Alzheimer’s trial misses goal, Green Dot to be acquired
- Waldencast Expands U.S. Market Presence with Novaestiq Acquisition
- Waldencast Reports Q2 2025 Results and Strategic Updates
